Biotechgiant
@CSL will spend $800m building a
#newVaccine manufacturing plant at the Melbourne Airport Business Park, with ops to start in 2026. The plant will utilise cell-based mass production techniques, complementing its existing vaccine capabilities.
buff.ly/2IFxjbE